drugset / Trial / NCT07320781
Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.
RandomizedParallel-groupDouble-blindPrevention
Summary
This study evaluated the preemptive analgesic efficacy of Tapentadol in reducing peri operative analgesic requirements among patients undergoing breast cancer surgery.
Timeline
- Start
- 2024-11-15
- Primary completion
- 2025-09-30
- Completion
- 2025-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tapentadol | Small molecule | 75 mg | Oral |